Muscular Dystrophy, Duchenne Concept

Vocabulary Service

MeSH

Overview

subject area of

236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1–3 June 2018 Journal Articles
A Population-Based Study of Dystrophin Mutations in Canada Journal Articles
AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy Journal Articles
AMPK is mitochondrial medicine for neuromuscular disorders Journal Articles
Acute, next‐generation AMPK activation initiates a disease‐resistant gene expression program in dystrophic skeletal muscle Journal Articles
Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review Journal Articles
Chronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle Journal Articles
Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders Journal Articles
Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles Journal Articles
Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy Journal Articles
Early Regional Myocardial Dysfunction in Young Patients With Duchenne Muscular Dystrophy Journal Articles
Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H₂O₂ emission during impaired oxidative phosphorylation Journal Articles
Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L Conferences
Exercise biology of neuromuscular disorders Journal Articles
Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy Journal Articles
Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain Journal Articles
Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI) Journal Articles
Histomorphometry and Bone Matrix Mineralization Before and After Bisphosphonate Treatment in Boys With Duchenne Muscular Dystrophy: A Paired Transiliac Biopsy Study Journal Articles
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy Journal Articles
Interstitial Cell Remodeling Promotes Aberrant Adipogenesis in Dystrophic Muscles Journal Articles
Loss of dystrophin expression in skeletal muscle is associated with senescence of macrophages and endothelial cells Journal Articles
Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice Journal Articles
Men on the margin: A Bourdieusian examination of living into adulthood with muscular dystrophy Journal Articles
Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity Journal Articles
Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle Journal Articles
Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20. Journal Articles
Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice Journal Articles
Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial Journal Articles
Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies Journal Articles
Nutritional therapy improves function and complements corticosteroid intervention in mdx mice Journal Articles
Patients with dystrophinopathy show evidence of increased oxidative stress Journal Articles
Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop Conferences
Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: Impacts, challenges, and opportunities Journal Articles
Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis Journal Articles
Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy Journal Articles
Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy Journal Articles
Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial Journal Articles
Tests for differential gene expression using weights in oligonucleotide microarray experiments Journal Articles
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy Journal Articles
The therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targets Journal Articles
The time to and determinants of first fractures in boys with Duchenne muscular dystrophy Journal Articles
Therapeutic targeting of mitochondria in muscular dystrophies. Editorial focus on: “Mitochondrial creatine sensitivity is lost in the D2.mdx model of Duchenne muscular dystrophy and rescued by the mitochondrial-enhancing compound Olesoxime” Journal Articles
Two children with muscular dystrophies ascertained due to referral for diagnosis of autism. Journal Articles
Unravelling protein turnover in Duchenne muscular dystrophy: one protein at a time Journal Articles
Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation Journal Articles
“You Take This Day by Day, Come What May”: A Qualitative Study of the Psychosocial Impacts of Living with Duchenne Muscular Dystrophy Journal Articles